Wave Life Sciences Ltd. Financial Ratios — WVE Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-38.61	-74.31	-137.73	-282.52	-204.64	-212.09	- -	- -	-77.87	-56.16
Return on Assets (%)	- -	-198.78	-22.81	-33.71	-58.84	-61.39	-66.75	-53.21	-50.28	-91.58	-27.3	-30.94	-41.26
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	-12,305.26	-5,030.77	-2,574.78	-1,068	-1,245.8	-714.22	-286.06	-4,182.13	-51.89	-93.94	-483.37
Operating Margin (%)	- -	- -	-12,696.05	-5,102.56	-2,630.13	-1,106.72	-1,303.37	-763.94	-310.07	-4,459.3	-60.01	-101.94	-504.09
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-12,602.63	-5,052.93	-2,597.95	-1,016.96	-1,211.52	-750.86	-298.92	-4,416.06	-51.36	-89.57	-478.33
Profit Margin (%)	- -	- -	-12,631.58	-5,097.07	-2,619.57	-1,017.43	-1,211.52	-746.68	-298.42	-4,434.72	-50.76	-89.57	-478.33
Net Income to Common Margin (%)	- -	- -	-12,631.58	-5,097.07	-2,619.57	-1,017.43	-1,211.52	-746.68	-298.42	-4,434.72	-50.76	-89.57	-478.33
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-38.61	-74.31	-137.73	-282.52	-204.64	-212.09	- -	- -	-77.87	-56.16

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	10	- -	- -	- -	3	10	33	29	30	38	32	25	18
ST Debt	10	- -	- -	- -	- -	1	3	4	5	5	7	8	8
LT Debt	- -	- -	- -	- -	3	9	29	26	25	32	25	18	9
Total Debt/EBITDA	-2.91	- -	-0.01	- -	-0.03	-0.07	-0.16	-0.2	-0.26	-0.25	-0.55	-0.25	-0.09
Net Debt/EBITDA	-2.78	0.2	8.62	2.74	1.42	1.14	0.74	1.29	1.28	0.58	3.41	2.97	2.92
Total Debt/EBIT	-2.69	- -	-0.01	- -	-0.03	-0.07	-0.16	-0.19	-0.24	-0.23	-0.47	-0.23	-0.08
Net Debt/EBIT	-2.56	0.19	8.35	2.7	1.39	1.1	0.71	1.2	1.19	0.54	2.95	2.74	2.8
EBITDA to Interest Expense	- -	-426.08	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	-475.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	-449.5	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-421.18	-199.01	92.79	81.83	76.78	24.78	22.42	29.64	15.7	-30.8	14.41	59.49	81.18
Long-Term Debt/Equity (%)	- -	- -	0.05	0.1	2.22	12.61	45.98	30.92	76.79	- -	64.1	8.48	1.81
Long-Term Debt/Capital (%)	- -	- -	0.05	0.1	2.16	11.04	30.44	22.83	39.98	-429.56	35.41	7.56	1.75
Long-Term Debt/Total Assets (%)	- -	- -	0.05	0.08	1.7	3.12	10.31	9.16	12.06	21.94	9.24	5.04	1.47
Total Debt/Equity (%)	-123.71	- -	0.09	0.15	2.47	14.18	51.07	35.4	92.05	-83.42	81.04	12.13	3.43
Total Debt/Capital (%)	521.85	- -	0.09	0.15	2.41	12.42	33.8	26.15	47.93	-503.06	44.77	10.81	3.31
Total Debt/Total Assets (%)	413.34	- -	0.08	0.12	1.9	3.52	11.45	10.49	14.45	25.7	11.68	7.21	2.78
Net Debt to Equity	-118.05	-51.7	-105.04	-111.44	-102.07	-238.34	-230.91	-222.88	-463.3	196.26	-505.55	-144.18	-116.15
Net Debt/Capital (%)	654.03	-107.05	2,124.39	987.15	-25,401.6	191.97	289.22	254.78	170.8	92.21	155.79	449.8	912.99
EBITDA	-3	-5	-19	-55	-100	-154	-199	-143	-117	-153	-59	-102	-207
EBITDA-CapEx	-3	-6	-21	-61	-119	-164	-203	-145	-118	-154	-60	-103	-207
Operating Income (Loss)	-4	-5	-19	-56	-102	-160	-208	-153	-127	-163	-68	-110	-215

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.04	1.19	42.23	12.36	7.83	1.34	1.25	1.52	2.35	1.24	1.07	2.72	6.33
Current Ratio	0.08	1.69	42.27	12.5	8.27	1.56	1.57	1.9	2.53	1.38	1.26	2.89	6.47
Quick Ratio	0.05	1.41	42.23	12.36	7.89	1.42	1.41	1.77	2.35	1.24	1.19	2.74	6.35
CFO/Avg Current Liab	- -	-0.81	-5.33	-4	-5.51	-0.31	-1.52	-0.97	-0.96	-1.88	-0.15	-1.02	-1.82
Common Equity/Total Assets	-421.18	-199.01	92.79	81.83	76.78	24.78	22.42	29.64	15.7	-30.8	14.41	59.49	81.18
Long-Term Debt/Equity (%)	- -	- -	0.05	0.1	2.22	12.61	45.98	30.92	76.79	- -	64.1	8.48	1.81
Long-Term Debt/Capital (%)	- -	- -	0.05	0.1	2.16	11.04	30.44	22.83	39.98	-429.56	35.41	7.56	1.75
Long-Term Debt/Total Assets (%)	- -	- -	0.05	0.08	1.7	3.12	10.31	9.16	12.06	21.94	9.24	5.04	1.47
Total Debt/Equity (%)	-123.71	- -	0.09	0.15	2.47	14.18	51.07	35.4	92.05	-83.42	81.04	12.13	3.43
Total Debt/Capital (%)	521.85	- -	0.09	0.15	2.41	12.42	33.8	26.15	47.93	-503.06	44.77	10.81	3.31
Total Debt/Total Assets (%)	413.34	- -	0.08	0.12	1.9	3.52	11.45	10.49	14.45	25.7	11.68	7.21	2.78
CFO/Total Liabilities	-35.21	-485.84	-104.98	-106.6	-198.12	-10.27	-85.36	-59.04	-51	-66.73	-8.26	-105.84	-156.06
CFO/CapEx	-75.55	-7.5	-6.75	-5.73	-4.43	-2.3	-48.04	-86.68	-158.92	-93.89	-17.43	-161.01	-261.13
Altman's Z-Score	-16.28	-13.38	17.75	11.45	11.43	0.3	-3.96	-3.53	-6.06	-10.77	-3.87	3.49	12.95

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	1.52	- -	7.79	2.62	1.07	0.8	2.73	- -	10.75	9.62	31.67
Days Sales Outstanding	- -	- -	240.13	- -	46.88	139.27	342.55	454.5	133.65	- -	33.96	37.93	11.52
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	344	615	977	1,239	275	384	188	608	602	1,893	3,190
- Cash & Cash Equivalents	- -	1	161	150	143	175	147	184	151	88	200	302	602
+ Preferred Equity and Hybrid Capital	2	8	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	10	- -	- -	- -	3	10	33	29	30	38	32	25	18
Enterprise Value	11	7	183	464	838	1,075	161	229	67	558	434	1,616	2,606
Total Capital	2	2	154	135	143	84	96	112	62	-7	72	235	536
Total Debt/Capital (%)	521.85	- -	0.09	0.15	2.41	12.42	33.8	26.15	47.93	-503.06	44.77	10.81	3.31
Total Debt / EV	0.86	- -	- -	- -	- -	0.01	0.2	0.13	0.44	0.07	0.07	0.02	0.01
EV/Sales	- -	- -	1,201.74	425.36	215.19	74.55	10.06	11.39	1.64	152.81	3.83	14.92	60.99
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	167	596	931	1,218	272	309	163	552	536	1,710	2,867
Diluted Enterprise Value	11	7	6	446	792	1,053	157	154	42	501	368	1,434	2,283
EV per Share	0.57	0.35	8.48	19.76	30.1	36.46	4.68	4.69	1.12	6.41	3.64	10.56	13.89
TTM Sales	- -	- -	- -	1	4	14	16	20	41	4	113	108	43
TTM EBITDA	-3	-5	-19	-55	-100	-154	-199	-143	-117	-153	-59	-102	-207
TTM Operating Income	-4	-5	-19	-56	-102	-160	-208	-153	-127	-163	-68	-110	-215
TTM Cash Flow to Firm	-4	-4	-13	-32	-84	-23	-188	-116	-89	-128	-19	-151	-187
TTM Free Cash Flow to Firm	-4	-4	-11	-26	-65	-13	-184	-115	-88	-126	-18	-150	-187

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-15.7	-22.62	-14.36	-94.24	-1.47	-2.69	-1.84	-4.37	-29.25	-11.4	-15.35
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	11	7	183	464	838	1,075	161	229	67	558	434	1,616	2,606
Low Price	- -	- -	11.52	8.95	15.15	31.65	7.78	6.61	3.07	1.16	3.15	3.5	5.28
EV/Sales	- -	- -	1,201.74	425.36	215.19	74.55	10.06	11.39	1.64	152.81	3.83	14.92	60.99
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-8.58	-8.8	-6.41	-8.63	-5.05	-2.44	-2.78	-1.5	-8.55	-10.76	-7.37
Price/Earnings High	- -	- -	-11.49	-16.45	-10.32	-11.06	-8.51	-5.23	-5.16	-3.45	-13.13	-23.86	-17.93
Price/Earnings Low	- -	- -	-6.3	-3.67	-3.94	-6.25	-1.36	-1.73	-1.3	-0.57	-5.81	-4.99	-4.36
Price/Book Value	- -	- -	2.24	4.56	7	16.89	4.32	4.64	5.78	-13.49	15.18	9.04	6.15
Price/Book Value Average	- -	- -	2.2	3.74	4.92	17.55	15.56	5.5	12.07	-5.94	13.94	5.51	3.23
Price/Book Value High	- -	- -	2.95	7	7.91	22.5	26.21	11.77	22.41	-13.67	21.41	12.23	7.87
Price/Book Value Low	- -	- -	1.62	1.56	3.02	12.72	4.19	3.9	5.65	-2.24	9.47	2.56	1.91
Price/Tangible Book Value	- -	- -	2.24	4.56	7	16.89	4.32	4.64	5.78	-13.49	15.18	9.04	6.15
Price/Tangible Book Value Average	- -	- -	2.2	3.74	4.92	17.55	15.56	5.5	12.07	-5.94	13.94	5.51	3.23
Price/Tangible Book Value High	- -	- -	2.95	7	7.91	22.5	26.21	11.77	22.41	-13.67	21.41	12.23	7.87
Price/Tangible Book Value Low	- -	- -	1.62	1.56	3.02	12.72	4.19	3.9	5.65	-2.24	9.47	2.56	1.91
Price/Sales	- -	- -	1,101.96	546	239.05	84.5	16.99	15.38	3.97	151.27	4.73	15.79	67.1
Price/Sales Average	- -	- -	1,083.35	448.38	168.01	87.79	61.2	18.22	8.29	66.58	4.34	9.64	35.27
Price/Sales High	- -	- -	1,450.86	838.32	270.38	112.55	103.06	39.04	15.4	153.22	6.67	21.37	85.77
Price/Sales Low	- -	- -	795.9	186.87	103.18	63.61	16.49	12.92	3.88	25.07	2.95	4.47	20.84
Price/Cash Flow	- -	- -	-13.37	-18.68	-11.12	-53.27	-1.44	-2.66	-1.83	-4.32	-27.57	-11.33	-15.29
Price/Cash Flow Average	- -	- -	-13.15	-15.34	-7.82	-55.35	-5.2	-3.15	-3.82	-1.9	-25.31	-6.91	-8.04
Price/Cash Flow High	- -	- -	-17.6	-28.67	-12.58	-70.96	-8.75	-6.76	-7.09	-4.38	-38.88	-15.33	-19.55
Price/Cash Flow Low	- -	- -	-9.66	-6.39	-4.8	-40.11	-1.4	-2.24	-1.79	-0.72	-17.2	-3.2	-4.75
Price/Free Cash Flow Average	- -	- -	-15.43	-18.58	-10.1	-97.91	-5.31	-3.19	-3.84	-1.92	-26.85	-6.95	-8.07
Price/Free Cash Flow High	- -	- -	-20.67	-34.73	-16.25	-125.53	-8.94	-6.84	-7.13	-4.42	-41.24	-15.42	-19.62
Price/Free Cash Flow Low	- -	- -	-11.34	-7.74	-6.2	-70.95	-1.43	-2.26	-1.8	-0.72	-18.25	-3.22	-4.77
EV/Sales Average	- -	- -	1,163.54	324.73	140.63	77.9	54.88	14.93	6.63	59.45	3.39	8.11	25.57
EV/Sales High	- -	- -	1,917.76	726.67	248.08	103.1	97.34	40.81	14.83	154.95	6	21.1	81.76
EV/Sales Low	- -	- -	573.63	55.18	72.58	53.31	9.54	8.33	1.54	13.69	1.83	2.39	9.51
EV/EBITDA Average	-3.39	-1.34	-9.46	-6.45	-5.46	-7.29	-4.41	-2.09	-2.32	-1.42	-6.53	-8.63	-5.29
EV/EBITDA High	-3.39	-1.34	-15.58	-14.44	-9.63	-9.65	-7.81	-5.71	-5.19	-3.71	-11.57	-22.46	-16.92
EV/EBITDA Low	-3.39	-1.34	-4.66	-1.1	-2.82	-4.99	-0.77	-1.17	-0.54	-0.33	-3.52	-2.55	-1.97
EV/EBIT Average	-3.13	-1.27	-9.16	-6.36	-5.35	-7.04	-4.21	-1.95	-2.14	-1.33	-5.65	-7.95	-5.07
EV/EBIT High	-3.13	-1.27	-15.11	-14.24	-9.43	-9.32	-7.47	-5.34	-4.78	-3.47	-10	-20.7	-16.22
EV/EBIT Low	-3.13	-1.27	-4.52	-1.08	-2.76	-4.82	-0.73	-1.09	-0.5	-0.31	-3.05	-2.35	-1.89
Last Price	- -	- -	15.95	26.15	35.1	42.04	8.02	7.87	3.14	7	5.05	12.37	17
High Price	- -	- -	21	40.15	39.7	56	48.64	19.98	12.17	7.09	7.12	16.74	21.73
Enterprise Value Average	11	7	177	355	547	1,123	877	300	272	217	384	878	1,092
Enterprise Value High	11	7	291	794	966	1,486	1,556	819	608	565	680	2,285	3,494
Enterprise Value Low	11	7	87	60	283	768	153	167	63	50	207	259	407

Shares Outstanding	20	20	22	24	28	29	34	49	60	87	119	153	188
Diluted Weighted Avg Shares	21	21	11	23	27	29	34	39	52	79	106	138	169
Basic Weighted Avg Shares	21	21	11	23	27	29	34	39	52	79	106	138	169
Revenue per Share	- -	- -	0.01	0.05	0.15	0.5	0.47	0.51	0.79	0.05	1.07	0.78	0.25
EBITDA per Share	-0.16	-0.24	-1.78	-2.41	-3.78	-5.31	-5.88	-3.66	-2.26	-1.94	-0.55	-0.74	-1.22
Operating Income per Share	-0.17	-0.26	-1.84	-2.44	-3.86	-5.51	-6.15	-3.91	-2.45	-2.06	-0.64	-0.8	-1.28
Basic EPS, GAAP	-0.16	-0.25	-1.83	-2.44	-3.85	-5.06	-5.72	-3.82	-2.36	-2.05	-0.54	-0.7	-1.21
Basic EPS from Cont Ops	-0.16	-0.25	-1.83	-2.44	-3.85	-5.06	-5.72	-3.82	-2.36	-2.05	-0.54	-0.7	-1.21
Diluted EPS, GAAP	-0.16	-0.25	-1.83	-2.44	-3.85	-5.06	-5.72	-3.82	-2.36	-2.05	-0.54	-0.7	-1.21
Diluted EPS from Cont Ops	-0.16	-0.25	-1.83	-2.44	-3.85	-5.06	-5.72	-3.82	-2.36	-2.05	-0.54	-0.7	-1.21
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.17	-0.21	-1.19	-1.4	-3.16	-0.79	-5.56	-2.96	-1.72	-1.62	-0.18	-1.09	-1.11
Free Cash Flow per Basic Share	-0.17	-0.24	-1.37	-1.64	-3.87	-1.13	-5.67	-2.99	-1.73	-1.64	-0.19	-1.1	-1.12
Cash & Equivalents per Share	0.02	0.05	7.48	6.39	5.12	5.93	4.29	3.78	2.52	1.02	1.68	1.97	3.21
Book Value per Share	-0.5	-0.3	7.12	5.74	5.02	2.49	1.86	1.7	0.54	-0.52	0.33	1.37	2.76
Tangible Book Value per Share	-0.5	-0.3	7.12	5.74	5.02	2.49	1.86	1.7	0.54	-0.52	0.33	1.37	2.76

Wave Life Sciences Ltd.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)